-
Few Trade Ideas for Friday, July 29
Thursday, July 28, 2011 - 5:54pm | 1452( click to enlarge ) Pharmacyclics, Inc. (NASDAQ:PCYC) is firming just above its 20-day moving average over the last few days. This is a neutral pattern dependent on a break to establish a directional bias. A break below $11.80 would signal a decline and be quite bearish, on the other hand...
-
Rodman & Renshaw Maintains Spectranetics Market Outperform, $9 PT
Thursday, July 28, 2011 - 2:09pm | 83Rodman & Renshaw maintained its Spectranetics (NASDAQ: SPNC) Market Outperform rating and $9 price target in a research report published today. In the report, Rodman & Renshaw states, "We are curious of what new strategic initiatives the new CEO will be embarking upon. To us, the next two...
-
Earnings Preview: Becton, Dickinson and Company EPS, Revenue Expected to Rise from Previous Quarter
Thursday, July 28, 2011 - 12:34pm | 573Becton, Dickinson and Company (NYSE: BDX) releases its next round of earnings this Tuesday, August 2, 2011. Here's Benzinga's advanced look at Becton, Dickinson and's third quarter earnings report. Earnings and Revenue: Analysts are predicting an EPS reading of $1.43 per share and revenues of...
-
Bank of America Comments on Failure of Hill-Rom Holdings to Meet Expectations
Thursday, July 28, 2011 - 9:07am | 169Bank of America has published a report on Hill-Rom Holdings (NYSE: HRC) after results failed to meet expectations for the medical technology manufacturer. In the report, Bank of America wrote, "HRC reported a very surprising Q3 miss on both the top and bottom line. After reiterating full year...
-
Wunderlich Securities Reiterates Hold and PT of $65 on Zimmer Holdings
Thursday, July 28, 2011 - 8:52am | 43Wunderlich Securities reiterated its Hold rating on Zimmer Holdings (NYSE: ZMH). At the same time, the rating agency left its price target on the company's stock unchanged at $65. On Wednesday, ZMH closed the day at $60.84.
-
Deutsche Bank Evaluates Zimmer Holdings at 2Q11
Thursday, July 28, 2011 - 8:48am | 142Deutsche Bank has published a report on Zimmer Holdings (NYSE: ZMH) maintaining their previous evaluation of the medical developer. In the report, Deutsche Bank wrote, "2Q sales and EPS were above First Call/DBe, but mostly due to FX, and lower R&D/tax rate. Y/Y recon and Americas sales, as...
-
News Summary for July 28, 2011
Thursday, July 28, 2011 - 7:53am | 584This is your Benzinga news summary and traders' outlook for Thursday, July 28, 2011, covering headlines from overnight and Thursday's pre-market session. Today in domestic pre-market trading, U.S. equity futures are trading flat as traders wait for the decision on the debt ceiling and the weekly...
-
A Peek Into The Market Before The Trading Starts
Thursday, July 28, 2011 - 7:22am | 372Pre-open movers US stock futures are slightly higher this morning, amid concerns over sovereign debt. Futures for the Dow Jones Industrial Average gained 14 points to 12,258.00 and S&P 500 index futures rose 2.70 points to 1,301.60. Nasdaq 100 futures climbed 6 points to 2,363.75. A Peek Into...
-
Boston Scientific Announces $1.0B Share Repurchase Program
Thursday, July 28, 2011 - 6:51am | 134Boston Scientific Corporation's (NYSE: BSX) Board of Directors has approved a new program authorizing the repurchase of up to $1.0 billion of its common stock and re-approving the approximately 37 million shares remaining under an existing share repurchase program. "This repurchase program...
-
JP Morgan Reiterates Overweight and PT of $70 on Zimmer Holdings
Thursday, July 28, 2011 - 6:38am | 48JP Morgan reiterated its Overweight rating on Zimmer Holdings (NYSE: ZMH). At the same time, the rating agency left its price target on the company's stock unchanged at $70. On Wednesday, ZMH lost 1.2% of its value to end the day at $60.84.
-
Earnings Scheduled For July 28
Thursday, July 28, 2011 - 5:02am | 559Astrazeneca PLC (NYSE: AZN) is expected to report its Q2 EPS at $1.80 on revenue of $8.19 billion. Exxon Mobil Corporation (NYSE: XOM) is projected to report its Q2 EPS at $2.33 on revenue of $121.39 billion. Bristol-Myers Squibb Company (NYSE: BMY) is estimated to report its Q2 EPS at $0.55 on...
-
Stocks to Watch for Thursday 7/28/2011: Fresh 52 Week Highs and Lows
Thursday, July 28, 2011 - 2:37am | 3403Stocks trading at or near 52-week highs and lows provide excellent trading opportunities, as volatility tends to increase at such levels and entry/exit points become more clearly defined. The following stocks hit new 52-week highs in Wednesday's trading session (listed from highest total volume to...
-
Wednesday's S&P 500 Sector Recap: Hottest and Coldest Sectors
Wednesday, July 27, 2011 - 5:36pm | 1734The S&P 500 (SPX) took a major hit in Wednesday's trading session, finishing down 27.05 points, or 2.03%, from Tuesday's close to 1304.89. The selling began just after the opening bell, and the index extended its losses throughout the session, closing near the low of the day (1303.49), as...
-
Biotech Stocks to Watch for Thursday
Wednesday, July 27, 2011 - 5:31pm | 3093( click to enlarge ) MELA Sciences, Inc. (NASDAQ:MELA) had a great move on the upside today and closed at $2.67. The stock is setting up to break out and has one more level to go, which is $2.72. MELA Sciences is a well capitalized company, with $1.03 in cash per share. This stock has a...
-
Scottish Executive Awards Varian Medical Systems Major Contract to Supply Radiotherapy Equipment to Scotland's Five Cancer Centers
Wednesday, July 27, 2011 - 4:47pm | 56Varian Medical Systems (NYSE: VAR) has been awarded a contract to supply eight TrueBeam treatment systems to hospitals in Scotland as part of a major nationwide procurement program. The award also involves two Clinac® iX linear accelerators, ancillary equipment and software from Varian, the world...